On a similar note, and as supportive evidence, inhibition of mitochondrial oxidative phosphorylation by phenformin associated with BRAF inhibitor PLX4720 was able to induce tumor regression in a genetically engineered BRAFV600E/PTEN null-driven mouse model of melanoma and in nude mice bearing melanoma xenografts [34]. The gene discussed is PTEN; the disease is neoplasm.